Related Stocks: NAS:URGN,...
Urogen UroGen (URGN) will face a pivotal regulatory test at the upcoming May 21, 2025 ODAC meeting f...
Balyasny Asset Management L.P. cut its stake in shares of UroGen Pharma Ltd. (NASDAQ:URGN – Free Rep...
UroGen Pharma Ltd. (NASDAQ:URGN - Free Report) - Investment analysts at HC Wainwright upped their Q2...
Related Stocks: NAS:URGN,...